Fladgate was pleased to act for KCR Residential REIT plc on the subscription by private equity fund, Torchlight for 9 million ordinary shares for a total subscription of £4.05m and the grant of an option to subscribe for an additional 50 million ordinary shares. KCR intends to consolidate its presence in the UK and to […]
Introduction EU Regulation 2017/1129 and its Delegated Regulation (dated 14 March 2019) come into force on 21 July 2019 in full, replacing the previous prospectus regime. The principal purpose of the reforms is to make it easier and less costly for businesses to access the capital markets by reducing the regulatory burden on issuers, and […]
Fladgate LLP is pleased to have advised Argo Blockchain Plc (Argo), a provider of crypto-mining services, on its admission to the standard segment of the Official List and to trading on the London Stock Exchange’s Main Market. Argo raised £25m under a placing concurrent with admission and had a market capitalisation on admission of approximately […]
Fladgate advised AIM listed Caspian Sunrise plc on the acquisition of Kazakh company 3A Best Group JSC, for a consideration of US$24 million to be satisfied in shares. 3A Best holds an oil and gas licence covering 1,347km2 close to the Caspian port city of Aktau. Completion is subject to the satisfaction of certain conditions including […]
Fladgate advised Angus Energy plc on the issue of an unsecured zero coupon convertible note to Bergen Global Opportunity Fund, LP with a nominal value of £3,390,000. The net proceeds of £3 million completed the financing to acquire a 25% interest in, and the operatorship of, the Balcombe licence (PEDL244), from Cuadrilla Balcombe Limited and Lucas […]
Fladgate advised TSX and NASDAQ listed TransGlobe Energy Corporation, an independent international oil and gas company with exploration and production operations in Egypt and Canada, on its introduction to AIM. The company’s full year average production guidance for 2018 is between 14,200 and 15,600 barrels of oil per day. TransGlobe will be the first AIM […]
Fladgate has advised Main Market listed WideCells Group Plc on its £2m placing and the publication of a related prospectus. The financing will be used to provide working capital for the group and for the expansion and development of the WideCells, CellPlan and Wideacademy brands and products. WideCells is a healthcare services company focused on providing stem […]
Fladgate has advised Angus Energy Plc on its agreement to form a new partnership with Cuadrilla Balcombe Limited and Lucas Bolney Limited. Under the terms of the agreement, Angus will acquire a 25% interest in licence PEDL244 which includes the entire Balcombe field discovery. Angus will pay a total of £4 million, and has subsequently […]
Fladgate LLP has advised AIM listed Angus Energy plc on its £3m placing to increase the group’s capitalisation and financial flexibility. Net proceeds from the placing will be used to pay operational and associated costs related to the development of the Holmwood prospect; fund capital expenditures; assist with funding business development and potential acquisition activities; […]
Fladgate’s capital markets team has had an impressive run to the end of 2017 after successfully closing its fifth AIM listed transaction last week. Sirius Petroleum’s proposed re-admission to AIM and US$21.5m fundraising follows deals for Angus Energy, Papua Mining, Tri-Star Resources and Tiger Resource Finance. More details below: Sirius Petroleum plc: readmission to AIM as […]
João Andrade, CEO of Widecells, discusses the company’s ambitious growth plans in Biotech & Money – we’re delighted that he’s referenced the contribution made by Fladgate LLP and partner Paul Airley. Please see below for link to article. WideCells sets course for synergistic growth
Fladgate has advised WideCells Group PLC, the healthcare services provider to the stem cell industry, on its recent placing to raise gross funds of approximately £750,000. The proceeds will be used to accelerate the roll out of its three stem cell services divisions, CellPlan (the group’s stem cell insurance product), WideCells (the group’s stem cell storage […]
The legal content provided by Fladgate LLP is for information purposes only and should not be relied on in any specific case without legal or other professional advice.
Copyright is owned by Fladgate LLP and all rights in such copyright are reserved. Material is not to be reproduced in whole or in part without prior written consent.
Fladgate LLP is a limited liability partnership, registered in England and Wales with registered number OC334334. It is authorised and regulated by the Solicitors Regulation Authority, number 484783. The term partner is used to refer to a member of Fladgate LLP. A list of members is available at the registered office shown above.